TuHURA Biosciences, Inc.
HURA
$2.46
-$0.16-6.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -11.15% | -- | -80.53% | ||
| Total Depreciation and Amortization | -19.89% | -- | -4.72% | ||
| Total Amortization of Deferred Charges | -- | -- | 241.18% | ||
| Total Other Non-Cash Items | 32.00% | -- | 196.96% | ||
| Change in Net Operating Assets | -77.10% | -- | 227.22% | ||
| Cash from Operations | -82.27% | -- | -26.52% | ||
| Capital Expenditure | -99.53% | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | 81.51% | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -39.77% | -- | -- | ||
| Total Debt Issued | -- | -- | 82.61% | ||
| Total Debt Repaid | 30.98% | -- | -- | ||
| Issuance of Common Stock | 3,553.62% | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 81.70% | -- | -- | ||
| Cash from Financing | 84.42% | -- | 72.47% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 7.23% | -- | 306.83% | ||